Physicians' Academy for Cardiovascular Education

Managing the late consequences of CHD

Slides (presentation) - May 6, 2010

Managing the late consequences of CHD: What is the evidence for lipid management

Andrew Selwyn, MD
Brigham and Womens Hopsital
Harvard Medical School
Boston, USA

The resources are for educational purposes only. Click on the slides to review


Managing CHD

Managing the late consequences of CHD: What is the evidence for lipid management?
Andrew Selwyn, MD, Brigham and Womens Hopsital, Harvard Medical School, Boston, USA

View presentation, click on slides

CVD is the No. 1 cause of death in the US
ASCOT: Primary Prevention in High Risk Patients
Primary Prevention: LDL Lowering
Secondary Prevention: Lowering LDL with Statins
Steno-2: Effects of multifactorial intervention on CV outcomes
ASCOT:Treating BP and Lipids
Statins and the risk of diabetes
TNT:Lowering Cholesterol in Metabolic Syndrome
Does it matter how we lower LDL?
ENHANCE
Regression of Atherosclerosis
Regression of Atherosclerosis
Treatment of Advanced Atherosclerosis
Regression of Atherosclerosis
Lipid Lowering and Resolution of Atherosclerosis
Percent Change in Atheroma Volume
ILLUSTRATE: Secondary Endpoint
ILLUMINATE (announced Dec. 2, 2006)
Stable and Vulnerable Plaques
Regression of Atherosclerosis
Effects of Statin Therapy on Rho-kinase in CAD Patients
Rho-kinase (ROCK 2) is overactive in Metabolic Syndrome

Share this page with your colleagues and friends: